FDA Approved: * March 30, 2020 Pharm Company: *STRIDES PHARMA Category:Lungs (Pulmonary)
Roflumilast, sold under the trade name Daxas among others, is a drug that acts as a selective, long-acting inhibitor of the enzyme phosphodiesterase-4 (PDE-4). It has anti-inflammatory effects and is used as an orally administered drug for the treatment of inflammatory conditions of the lungs such as chronic obstructive pulmonary disease (COPD).[6][7][8][9]
In June 2010, it was approved in the European Union for severe COPD assoc...
[wikipedia]
* May have multiple approval dates, manufacturers, or labelers. 1 Discussion
